RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMM.L
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Immupharma Plc stock downgraded after the last trading session.
(Updated on Mar 27, 2024)

Buy or Hold candidate since Mar 11, 2024 Gain 73.06% PDF

No changes to the price of Immupharma Plc stock on the last trading day (Wednesday, 27th Mar 2024). During the last trading day the stock fluctuated 0% from a day low at £2.57 to a day high of £2.57. The price has risen in 6 of the last 10 days and is up by 64.22% over the past 2 weeks.

The stock lies in the upper part of a very wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at £2.57 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 2.67% during the next 3 months and, with a 90% probability hold a price between £0.89 and £2.64 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMM.L Signals & Forecast

The Immupharma Plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at £2.12 and £1.45. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, March 26, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Immupharma Plc stock

On the downside, the stock finds support just below today's level from accumulated volume at £2.24 and £2.00. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at £2.00 may give a huge drop in the stock price.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved £0 between high and low, or 0%. For the last week the stock has had daily average volatility of 22.51%

The Immupharma Plc stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: £2.48 (-3.34%) (This stock has low daily movements and this gives low risk. The RSI14 is 83 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (IMM.L) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Immupharma Plc to open at £2.57, and during the day (based on 14 day Average True Range), to move between £2.23 and £2.91, which gives a possible trading interval of +/-£0.337 (+/-13.11%) up or down from last closing price. If Immupharma Plc takes out the full calculated possible swing range there will be an estimated 26.22% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ £2.24, some £0.330 (12.84%) from the current price of £2.57, our system finds the risk reward attractive.

Is Immupharma Plc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immupharma Plc stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 1.265 Buy Candidate Downgraded

Predicted Opening Price for Immupharma Plc of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
£2.57 ( 0%) £2.57

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMM.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.57 .
R2 2.57 .
R1 2.57 .
Current price: 2.57
Support S1 2.57 .
S2 2.57 .
S3 2.57 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 2.57
Support S1 2.24 -12.84%
S2 2.00 -22.37%
S3 0 .

IMM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 14, 2021 Dec 14, 2021 Dec 14, 2021 £300.00 5,357.14%

FAQ

What is the symbol for Immupharma Plc Stock and on which exchange is it traded?
The symbol for Immupharma Plc is IMM.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell Immupharma Plc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immupharma Plc stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy Immupharma Plc Stock?
Immupharma Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immupharma Plc Stock.

What's the current price of Immupharma Plc Stock?
As of the end of day on the 2024-03-27, the price of an Immupharma Plc (IMM.L) share was £2.57.

What is the 52-week high and low for Immupharma Plc Stock?
The 52-week high for Immupharma Plc Stock is £3.80 and the 52-week low is £0.82.

What is the market capitalization of Immupharma Plc Stock?
As of the 2024-03-27, the market capitalization of Immupharma Plc is 10.432M.

When is the next earnings date for Immupharma Plc?
The upcoming earnings date for Immupharma Plc is May 09, 2024.
Click to get the best stock tips daily for free!

About Immupharma Plc

Immupharma Plc ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a... IMM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT